What Researchers Did
Researchers reviewed the current evidence on hyperbaric oxygen therapy (HBOT) as a treatment option for non-healing diabetic foot ulcers (DFUs).
What They Found
They found that hyperbaric oxygen therapy (HBOT) shows a positive trend towards increased wound healing and reduced amputation risk for diabetic foot ulcers (DFUs), which often fail to heal in up to 35% of cases with conventional treatment. While generally considered safe with mild and transient side effects, some controversy exists due to contradictory results in studies, possibly from grouping patients with and without peripheral arterial occlusive disease.
What This Means for Canadian Patients
Canadian patients with non-healing diabetic foot ulcers may consider hyperbaric oxygen therapy (HBOT) as a recognized treatment option to improve wound healing. This therapy could potentially reduce the risk of amputation and improve quality of life for those who have not responded to conventional treatments.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation noted is the controversy surrounding hyperbaric oxygen therapy efficacy due to contradictory results in existing studies, potentially from inconsistent patient grouping.